Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: Construction of Diagnosis System for Early AD Based on Multi-Modality MRI Technology
A completed clinical trial evaluated a multi-modality MRI-based system for diagnosing Alzheimer's disease at an early stage, including indiv…
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Conservation of Praxis in the Food and Alzheimer Disease
A clinical trial in Alzheimer's disease conducted at University Hospital, Limoges has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline [Phase 4]
Phase 4 trial results examine how Florbetapir (18F) PET imaging changes patient management in Alzheimer's disease and explore the relationsh…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: S-Equol in Alzheimer's Disease (SEAD) Trial [Phase 1]
This update notes the completion of the Phase 1 SEAD trial evaluating S-Equol for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update evaluating the efficacy and safety of ELND005 for agitation and aggression in Alzheimer's disease; study compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
A clinical trial evaluating sleep apnea in early- to mid-stage Alzheimer's disease has been terminated. The study was sponsored by Centre Ho…
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Exploratory Study for the Validity of QuQu Scale
This update reports the completion of an exploratory study to assess the validity of the QuQu Scale for Alzheimer’s disease.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) [Phase 3]
This entry documents a completed Phase 3 safety study of AVP-923 for involuntary emotional expression disorder (pseudobulbar affect). It inv…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training [Phase 4]
A Phase 4 trial evaluated memantine with comprehensive, individualized management of Alzheimer's disease and caregiver training; results wer…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Sensory-cognitive and Physical Fitness Training in Mild Cognitive Impairment [NA]
A completed clinical trial evaluated sensory-cognitive and physical fitness training for people with mild cognitive impairment and mild Alzh…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease [Phase 4]
Phase 4 trial evaluating safety and efficacy of donepezil HCl 23 mg in moderate to severe Alzheimer's disease; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: African American Alzheimer's Progression Markers - CSF and Neuro-Imaging
This update notes the completion of a clinical study evaluating cerebrospinal fluid biomarkers and neuro-imaging markers of Alzheimer's dise…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Resveratrol for Alzheimer's Disease [Phase 2]
This document reports the completion of a Phase 2 trial evaluating resveratrol for Alzheimer's disease and notes that the trial results were…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of plasma exchange with 5% albumin for clearing beta-amyloid in cerebrospinal flui…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients [Phase 3]
Pfizer's Phase 3 trial of bapineuzumab for Alzheimer's disease was terminated and results were posted.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Treatment of Behavioral Symptoms in Alzheimer's Disease [Phase 4]
A Phase 4 trial evaluating treatment of behavioral symptoms in Alzheimer's disease has completed, including psychosis and agitation.
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Oculomotor Testing in the Differential Diagnosis of Dementia [Phase 3]
Phase 3 clinical trial evaluating oculomotor testing to differentiate dementia with Lewy bodies from Alzheimer's disease; status completed.
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters [NA]
A completed study evaluating a telephone care consultation intervention for veterans with dementia and Alzheimer's disease; results were pos…
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED) [Phase 2]
The Phase 2 clinical trial MK0952 in mild-to-moderate Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease [Phase 2]
A 36-week safety extension study of ELND005 for agitation and aggression in Alzheimer's disease was terminated; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease [Phase 1]
This Phase 1 trial assessed the short-term efficacy and safety of perispinal administration of etanercept in individuals with mild to modera…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant Men
This completed clinical trial examined cerebrospinal fluid biomarkers related to Alzheimer's disease in insulin-resistant men. Sponsored by …
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Impact of Pharmacotherapy Management in Patients With Alzheimer's Disease [NA]
This report summarizes a completed clinical trial assessing how pharmacotherapy management affects outcomes in patients with Alzheimer's dis…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients
This clinical trial update reports on the tolerability of the Exelon Patch (rivastigmine) for patients with Alzheimer's disease and notes co…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025 [Phase 3]
This clinical trial update reports the termination of a Phase 3 study evaluating two doses of EVP-6124 in subjects with Alzheimer's disease …